Apollo Hospitals Enterprise Limited (APOLLOHOSP)
🎯 Key Takeaways
- Apollo Hospitals Enterprise Limited is undergoing a strategic restructuring through a composite scheme of arrangement involving demerger and separation of its healthcare technology arm, Apollo Healthtech. The company is repositioning its business structure to enhance focus, governance, and potential independent listing of its tech subsidiary.
- Revenue grew 2% QoQ to ₹6,606 in Q4FY26.
- ⚠️ 1) Execution risk from the complex restructuring process, including potential delays in NCLT or regulatory approvals for the new entities. 2) Integrat
📖 The Story
Apollo Hospitals Enterprise Limited is undergoing a strategic restructuring through a composite scheme of arrangement involving demerger and separation of its healthcare technology arm, Apollo Healthtech. The company is repositioning its business structure to enhance focus, governance, and potential independent listing of its tech subsidiary. This transformation is central to its current growth narrative, aiming to unlock value and improve capital allocation efficiency.
📰 What's Happening
In June 2026, shareholders and creditors approved the composite scheme of arrangement involving demerger, amalgamation, and rebranding, with 100% creditor value support and NCLT approval granted. The restructuring reorganizes Apollo Healthco, Keimed Private Limited, and Apollo Healthtech entities under a new framework. Management plans to reconstitute the board and list the new entities on stock exchanges, signaling a major strategic shift toward focused business units and potential value unlocking through separate listings.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5,086 | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 |
| Operating Profit | 712 | 854 | 825 | 831 | 892 | 996 | 999 | 1,055 |
| OPM % | 13.3% | 14.6% | 13.8% | 13.8% | 14.6% | 14.9% | 14.9% | 15.3% |
| Net Profit | 316 | 396 | 379 | 415 | 441 | 494 | 516 | 551 |
| EPS | ₹21.23 | ₹26.34 | ₹25.89 | ₹27.10 | ₹30.10 | ₹33.19 | ₹34.94 | ₹36.82 |
Revenue and profitability have shown consistent growth over the past eight quarters, with revenue rising from ₹5,086 crore in Q1FY25 to ₹6,606 crore in Q4FY26, and net profit increasing from ₹316 crore to ₹551 crore. Operating margins have expanded from 13.3% to 15.3%, indicating operational efficiency gains. EPS has grown from ₹21.23 to ₹36.82, reflecting strong bottom-line performance. This upward trajectory aligns with management's strategic investments in hospital networks and digital health initiatives.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance on revenue or margins in the latest filings, but the completion of the restructuring scheme and board reconstitution plans indicate a focus on execution and governance improvements. The company is positioning itself for a more focused operational model under the new entity structure, with future updates expected post-scheme effectiveness. Investors should monitor upcoming investor presentations or regulatory filings for updated strategic commentary.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | 2024-2025 | 2025-2026 | 2025-2026 | 2025-2026 | 2025-2026 |
|---|---|---|---|---|---|
| Equity Capital | 72 | 72 | 72 | 72 | 72 |
| Reserves | 8,140 | — | 9,021 | — | 9,408 |
| Borrowings | 5,275 | — | 5,341 | — | 5,659 |
| Total Liabilities | 12,005 | 6,405 | 12,397 | 6,480 | 12,222 |
| Fixed Assets | 9,816 | — | 9,965 | — | 11,039 |
| Investments | 2,263 | — | 2,780 | — | 1,922 |
| Total Assets | 20,657 | 21,331 | 21,950 | 22,447 | 22,197 |
The balance sheet shows stable equity of ₹72 crore with reserves growing from ₹9,021 crore to ₹9,408 crore, while borrowings remain elevated at ₹5,659 crore. Total assets have increased to ₹22,197 crore, indicating ongoing capital investment in infrastructure and expansion. The capital structure reflects a balanced approach with moderate leverage (D/E of 0.64), supporting growth initiatives while maintaining financial stability. Reserves growth suggests retained earnings are being reinvested or used for strategic purposes.
💰 Cash Flow Statement (₹ Cr)
| Item | 2020-2021 | 2020-2021 |
|---|---|---|
| Operating | +265 | +1,273 |
| Investing | +352 | -872 |
| Financing | -461 | -340 |
| Net Cash Flow | — | — |
⚖️ Peer Comparison — Healthcare Services
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | 1.16 L Cr | 64.5 | 20.5% | 21.9% | 0.64 |
| Max Healthcare Institute Limited | 1.02 L Cr | 101.2 | — | — | — |
| Fortis Healthcare Limited | 72,752 | 94.6 | — | — | — |
| Aster DM Healthcare Limited | 39,048 | 7.1 | — | — | — |
| Narayana Hrudayalaya Ltd. | 37,625 | 47.7 | — | — | — |
| Global Health Limited | 33,405 | 65.8 | — | — | — |
| Krishna Institute of Medical Sciences Limited | 30,477 | 80.3 | — | — | — |
| Dr. Lal Path Labs Ltd. | 26,871 | 63.6 | — | — | — |
| Syngene International Limited | 18,295 | 36.3 | — | — | — |
| Dr. Agarwal's Health Care Limited | 14,266 | 88.8 | 14.9% | 6.8% | 0.13 |
⚠️ Risk Factors
1) Execution risk from the complex restructuring process, including potential delays in NCLT or regulatory approvals for the new entities. 2) Integration challenges in separating Apollo Healthtech operations while maintaining service continuity. 3) High valuation multiples (P/E of 64.5) may limit upside if growth slows. 4) Rising operating costs from expansion in hospital networks could pressure margins if revenue growth moderates.
📋 Recent Filings
-
Announcement 3 July 2026Apollo Hospitals confirmed that securities were dematerialized and updated on NSE and BSE for the quarter ended June 30, 2026, as required under SEBI ...
-
🔴 Corporate Action 26 June 2026Apollo Hospitals Enterprise Limited announced that all resolutions for its composite scheme of arrangement involving demerger, amalgamation and rebran...
-
Financial Results 25 June 2026Apollo Hospitals announced that its trading window will close on 1 July 2026 for 48 hours following the release of unaudited quarterly results ending ...
-
🔴 Corporate Action 24 June 2026Apollo Hospitals announced the completion of its scheme of arrangement meeting held on June 24, 2026, where secured, unsecured creditors and equity sh...
-
🔴 Corporate Action 19 June 2026Apollo Hospitals announced a composite scheme of arrangement involving its subsidiary Apollo Healthtech Limited, detailing promoter commitments to wai...
-
🔴 Announcement 16 June 2026No summary available
-
🔴 Corporate Action 15 June 2026Apollo Hospitals announced a composite scheme of arrangement involving Apollo Healthtech Limited, Transferor Company 1, and Transferor Company 2, seek...
-
🔴 Announcement 30 May 2026Apollo Hospitals announced the resignation of President - Group Oncology and International Dinesh Madhavan, effective close of business on May 30, 202...
-
🔴 Corporate Action 25 May 2026Apollo Hospitals Enterprise Limited announced a Scheme of Arrangement involving the demerger of its subsidiaries and restructuring of share capital, r...
-
Announcement 25 May 2026Apollo Hospitals Enterprise Limited announced a shareholder meeting on June 24, 2026, to approve a composite scheme of arrangement involving its demer...
🧠 Analyst's Read
Apollo Hospitals is transitioning into a more focused, structurally streamlined organization through its approved restructuring scheme. The next critical phase will be the successful execution of the demerger and listing of Apollo Healthtech, which will determine the pace of value unlocking. Investors should monitor management's capital allocation plans and execution timelines for the new entity setup.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.
📡 Get AI alerts when APOLLOHOSP files new disclosures
Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track APOLLOHOSP — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research